S.Science Company, Ltd. (5721) AI Stock Analysis

• Market Cap: ¥67.43B
• Dividend Yield: N/A
• Average Volume (3M): 16.50M
• Price to Earnings (P/E): ―
• Beta (1Y): 0.94
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: JP
• Employees: 27
• Sector: Industrials
• Sector Strength: 72
• Industry: Conglomerates
• EPS (TTM): -10.28
• Shares Outstanding: 613,004,200
• 10 Day Avg. Volume: 6,247,700
• 30 Day Avg. Volume: 16,499,810
• PEG Ratio: 1.37
• Price to Book (P/B): 5.72
• Price to Sales (P/S): 25.89
• P/FCF Ratio: -64.59
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 46 Neutral
• Price Target: ¥108.00 ▼(-53.04% Downside)
• Action: Reiterated Date: 03/10/26
• Date: Action: Reiterated 03/10/26

The score is held down primarily by weak financial performance (sharp revenue decline, return to losses, and consistently negative operating/free cash flow) and bearish technicals (price below key moving averages with negative MACD). A strong, low-debt balance sheet provides some downside resilience, but valuation is difficult to support with a negative P/E tied to current losses and no dividend yield data.

Positive Factors

Low Leverage

A near-zero debt profile and sizeable equity base materially reduce solvency and refinancing risk, giving management strategic optionality. Over 2–6 months this balance-sheet strength cushions operational losses, supports working-capital needs, and enables selective investment or M&A without immediate external funding.

Proven Profitability

The company demonstrated the ability to generate high net margins in FY2024, indicating that underlying operations can be profitable. This suggests existing business lines or cost structures can produce strong returns when revenue stabilizes, supporting potential durable recovery and reinvestment.

Lean Cost Base

A very small headcount points to a lean operating model with lower fixed overhead, which can preserve margins and allow faster scaling or restructuring. Over months this structural cost advantage aids cash conservation and makes it easier to align expenses to revenue recovery trajectories.

Negative Factors

Persistent Negative Cash Flow

Consistent negative operating and free cash flow indicates core operations do not produce sufficient cash, forcing reliance on reserves or financing. This undermines sustainable reinvestment, increases liquidity risk, and limits ability to support capex, R&D or dividends without altering operations or capital structure.

Sharp Revenue Decline

A nearly 50% revenue contraction is a structural red flag: it reduces scale economics, strains fixed-cost absorption, and can signal lost customers or demand shifts. Recovering scale takes time and creates lasting margin pressure, raising execution risk over the medium term.

Profitability Volatility

Large swings from strong profit to material losses reveal earnings instability and weak operating leverage. Such volatility complicates strategic planning, capital allocation, and creditor confidence, and suggests the business lacks durable demand or consistent margin protection across cycles.

S.Science Company, Ltd. Business Overview & Revenue Model

Company Description

S Science Company, Ltd. produces and sells nickel products primarily in Japan. The company offers s and p pellets/anodes, s and r round anodes, nickel plating chips, nickel balls and anodes, nickel sulfate, and nickel chloride. It also engages in the management of schools; brokering and mediation of real estate properties; and environment related business. The company was formerly known as Shimura Sangyo Co., Ltd. and changed its name to S Science Company, Ltd. in 2003. S Science Company, Ltd. was incorporated in 1946 and is headquartered in Tokyo, Japan.

How the Company Makes Money

S.Science Company, Ltd. generates revenue through the sale of its advanced materials and components to various industries. The company's key revenue streams include direct sales to electronics manufacturers, automotive companies, and healthcare providers who utilize its products in their production processes. Additionally, S.Science Company, Ltd. engages in strategic partnerships and collaborations that enhance its market presence and drive sales growth. The company's focus on innovation and R&D allows it to maintain a competitive edge, ensuring a steady demand for its cutting-edge solutions.

S.Science Company, Ltd. Financial Statement Overview

Summary

Financials are mixed but skew weak: income performance is highly volatile with a sharp FY2025 revenue contraction (~-49% YoY) and a return to net losses, while cash flow is persistently negative (negative operating cash flow and free cash flow across all periods). The key offset is a strong, low-leverage balance sheet (debt-to-equity ~0%) that provides resilience despite weak and unstable returns (ROE turning negative again in FY2025).

Income Statement

Revenue has been volatile and is now contracting sharply (FY2025 revenue down ~49% YoY after growth in FY2023–FY2024). Profitability is inconsistent: the company swung from a strong net profit in FY2024 (net margin ~28%) back to a net loss in FY2025 (net margin ~-15%), with operating losses persisting (negative EBIT margin in FY2025). Gross margins remain modest (roughly 8%–21% historically) and the recent drop in sales combined with negative operating leverage is a key weakness.

Balance Sheet

The balance sheet is a relative strength with essentially no leverage (debt-to-equity ~0% across periods) and a sizeable equity base (equity ~¥2.9B vs assets ~¥3.0B in FY2025). However, shareholder returns are weak and unstable, turning negative again in FY2025 (ROE ~-3%) after a strong FY2024, reflecting earnings volatility rather than balance-sheet stress.

Cash Flow

Cash generation is consistently weak: operating cash flow is negative every year shown (including FY2025 at roughly -¥253M), and free cash flow is also persistently negative. Free cash flow deterioration in FY2025 versus FY2024 is notable, and the pattern suggests earnings (when positive) are not translating into cash, increasing funding and execution risk despite low financial leverage.

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	1.24B	634.43M	718.71M	1.36B	1.16B	1.08B
Gross Profit	114.66M	71.83M	21.59M	229.87M	248.73M	180.49M
EBITDA	-86.63M	-89.66M	440.44M	-95.05M	-311.44M	-251.41M
Net Income	54.67M	-96.11M	389.50M	-105.52M	-329.38M	-269.62M
Balance Sheet
Total Assets	3.16B	3.01B	3.27B	2.95B	2.94B	2.01B
Cash, Cash Equivalents and Short-Term Investments	2.15B	2.18B	1.83B	1.31B	1.74B	969.37M
Total Debt	0.00	0.00	3.00M	3.00M	3.00M	3.00M
Total Liabilities	140.00M	135.60M	263.77M	316.80M	250.18M	216.12M
Stockholders Equity	3.02B	2.87B	3.01B	2.63B	2.69B	1.80B
Cash Flow
Free Cash Flow	726.00K	-254.29M	-149.97M	-142.79M	-454.46M	-76.13M
Operating Cash Flow	726.00K	-253.41M	-149.74M	-142.41M	-214.96M	-76.13M
Investing Cash Flow	0.00	259.71M	1.09B	-289.19M	-76.69M	-43.81M
Financing Cash Flow	0.00	-22.00K	-13.00K	-10.00K	1.22B	2.65M

S.Science Company, Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 230.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:5721, the sentiment is Negative. The current price of 230 is above the 20-day moving average (MA) of 121.85, above the 50-day MA of 141.99, and above the 200-day MA of 121.77, indicating a bearish trend. The MACD of -8.08 indicates Positive momentum. The RSI at 37.71 is Neutral, neither overbought nor oversold. The STOCH value of 18.92 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:5721.

S.Science Company, Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
5393	78 Outperform	¥539.87B	12.74	13.63%	1.95%	-1.33%	9.21%
5331	78 Outperform	¥178.35B	12.04	8.27%	2.68%	-2.45%	7.31%
3106	75 Outperform	¥139.13B	9.78	―	2.66%	-1.63%	67.13%
4206	73 Outperform	¥240.30B	9.23	―	3.90%	2.65%	7.16%
3105	65 Neutral	¥242.09B	14.72	8.35%	2.73%	3.35%	810.44%
Sector *	63 Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%
5721	46 Neutral	¥67.43B	-7.65	―	―	―	―